MBP Europe Limited was a VAT-registered company with substantial VAT liabilities each quarter. The amount owed for the ...
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback